Nanoparticles in pregnancy: the next frontier in reproductive therapeutics
Pre-clinical research in the development of nanoparticle therapeutic delivery is being undertaken in many fields of reproductive medicine. Non-hormonal-targeted nanoparticle therapy for fibroids and endometriosis may provide fertility-sparing medical management. Nanotherapeutic delivery offers options to stably deliver silencing RNA and microRNA inhibitors to the placenta. Alternatively, targeted delivery of drugs to the fetus may minimize side effects for the mother.
